ClinConnect ClinConnect Logo
Search / Trial NCT04117334

Determining Best Indications for Bracing for Adolescent Idiopathic Scoliosis

Launched by THE UNIVERSITY OF HONG KONG · Oct 4, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Bracing Cost Effectiveness Adolescent Idiopathic Scoliosis

ClinConnect Summary

This clinical trial is looking at the best ways to use braces for young people with adolescent idiopathic scoliosis (AIS), which is a condition that causes the spine to curve abnormally. The researchers want to find out if starting brace treatment earlier, even for smaller curves, and considering surgery for larger curves is more cost-effective while still keeping patients healthy and happy. They will gather information through questionnaires that ask about health-related quality of life and will also look at the costs involved in treatments. The goal is to help doctors make better decisions about when and how to start bracing for their patients.

To participate in this study, individuals must be diagnosed with adolescent idiopathic scoliosis and still have growth potential, as determined by specific criteria. The study is open to all genders, and participants will need to wear a specific type of brace as part of their treatment. Those who do not have AIS, cannot attend follow-ups, or refuse to participate will not be included. This research could lead to better care for AIS patients in Hong Kong and around the world.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who are diagnosed with adolescent idiopathic scoliosis and are seen in the first setting with remaining growth potential (Risser 0-2), and are prescribed with either underarm (Boston) or Milwaukee bracing
  • Exclusion Criteria:
  • Patients whose diagnosis is not adolescent idiopathic scoliosis, unable to comply with study follow-up and refused consent for study

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Jason Cheung, MBBS, MS

Principal Investigator

HKU/HA

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials